sibutramine has been researched along with dextroamphetamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Beake, B; Cole, JO; Kaiser, PE; Levin, A; Scheinbaum, ML | 1 |
| Aspley, S; Cheetham, SC; Heal, DJ; Jackson, HC; Martin, KF; Prow, MR | 1 |
| Heal, DJ; Hughes, ZA; Stanford, SC; Wortley, KE | 1 |
| Hopper, JA; Mendel, CM; Schuh, LM; Schuster, CR | 1 |
| Aspley, S; Butler, SA; Dykes, SG; Heal, DJ; Kilpatrick, IC; Prow, MR; Rowley, HL | 1 |
| Ryan, DH | 1 |
| Antón Fructuoso, P; Saiz González, D; Saiz Ruiz, J | 1 |
| Géranton, SM; Heal, DJ; Stanford, SC | 1 |
3 review(s) available for sibutramine and dextroamphetamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.
Topics: Animals; Biogenic Monoamines; Cyclobutanes; Dextroamphetamine; Energy Metabolism; Fenfluramine; Humans; Hypertension, Pulmonary; Obesity; Selective Serotonin Reuptake Inhibitors | 1998 |
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluramine; Heart Valve Diseases; Humans; Obesity; Phenylpropanolamine; Serotonin Agents; Weight Loss | 2000 |
2 trial(s) available for sibutramine and dextroamphetamine
| Article | Year |
|---|---|
Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines.
Topics: Adult; Affect; Appetite Depressants; Blood Pressure; Cyclobutanes; Dextroamphetamine; Double-Blind Method; Heart Rate; Humans; Male; Psychiatric Status Rating Scales; Stimulation, Chemical | 1998 |
Abuse liability assessment of sibutramine, a novel weight control agent.
Topics: Adult; Affect; Appetite Depressants; Blood Pressure; Cyclobutanes; Dextroamphetamine; Double-Blind Method; Euphoria; Heart Rate; Humans; Substance-Related Disorders; Surveys and Questionnaires | 2000 |
5 other study(ies) available for sibutramine and dextroamphetamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Appetite Depressants; Cerebral Cortex; Cyclobutanes; Dextroamphetamine; Idazoxan; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 1999 |
Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
Topics: Animals; Appetite Depressants; Central Nervous System Stimulants; Cyclobutanes; Dextroamphetamine; Dopamine; Eating; Male; Motor Activity; Nucleus Accumbens; Phentermine; Rats; Rats, Sprague-Dawley | 2000 |
[Abuse potential of sibutramine].
Topics: Appetite Depressants; Central Nervous System Stimulants; Cyclobutanes; Dextroamphetamine; Female; Humans; Middle Aged; Obesity; Substance-Related Disorders | 2003 |
5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclobutanes; Dextroamphetamine; Frontal Lobe; Hypothalamus; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 2004 |